✦ LIBER ✦

Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trial

✍ Scribed by Pierre Pouillart; Georges Mathe; Thao Hoang Thy; Jean Lheritier; Maurice Poisson; Pierre Huguenin; Henry Gauthier; Philippe Morin; Robert Parrot

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 627 KB
Volume: 38
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197611)38:5<1909::aid-cncr2820380507>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of procarbazine, CCNU, an

Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors

✍ Philip H. Gutin; Charles B. Wilson; A. R. Vansantha Kumar; Edwin B. Boldrey; Vic 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

A phase II trial of teniposide (VM 26) i

A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients

✍ Dr. Umberto Tirelli; Antonino Carbone; Diana Crivellari; Rachele Volpe; Giovanni 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 3 views

Phase II trial of irinotecan plus celeco

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

✍ David A. Reardon; Jennifer A. Quinn; James Vredenburgh; Jeremy N. Rich; Sridhara 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract ## BACKGROUND In the current study, the authors report a Phase II trial of irinotecan (CPT‐11), a topoisomerase I inhibitor active against malignant glioma (MG), with celecoxib, a selective COX‐2 inhibitor, among MG patients with recurrent disease. ## METHODS Patients with MG at any

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci

Topotecan as a radiosensitizer in the tr

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a French Society of Paediatric Oncology Phase II Study

✍ Valerie Bernier-Chastagner; Jacques Grill; Francois Doz; Serge Bracard; Jean Cla 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND The current Phase II study was conducted to evaluate the survival and toxicity observed in children with newly diagnosed brainstem gliomas who were treated with the daily radiotherapy with topotecan used as a radiosensitizer. ## METHODS Eligible patients were those ages

Phase I trial of irinotecan plus temozol

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

✍ David A. Reardon; Jennifer A. Quinn; Jeremy N. Rich; Annick Desjardins; James Vr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB